Looking ahead for the Nifty-50 index, the recent swing low of 24598 is anticipated to serve as a support level, as per experts

Revenue up 21.7% at Rs 5,521 crore versus Rs 4,538 crore.Ebitda up 38.9% at Rs 878 crore versus Rs 632 crore.Margin at 15.9% versus 13.9%.Net Profit up 50.8% at Rs 855 crore versus Rs 567 crore.Sun Pharma Q1 Highlights (Consolidated,

The yield on the 10-year hit a 52-week high of 4.896% on January 13, a week before Trump's second inauguration, and traded as low as 3.860% on April 4 before spiking to 4.607% on May 21, then settling at 4.431% on July 18.